Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies by unknown
Effect of Antigen/Antibody Ratio on Macrophage
Uptake, Processing, and Presentation to T Cells of
Antigen Complexed with Polyclonal Antibodies
By Fabrizio Manca, Daniela Fenoglio, Giuseppina Li Pira, Annalisa
Kunkl, and Franco Celada
From the Department of Immunology, University of Genoa, San Martino Hospital, 16132
Genoa, Italy.
Summary
Activation of a galactosidase-specific murine T hybridoma clone and of a human tetanus
toxoid-specific T clone by antigen-presenting cells (APC) was used to evaluate the regulatory
function ofantibodies complexed with the relevant antigen. Complexed antigen, in fact, is taken
up with high efficiency thanks to Fc receptors borne by APC. Antibody/antigen ratio in the
complexes proved to be a critical parameter in enhancing antigen presentation. Complexes in
moderate antibody excess provided optimal T cell activation independently of the physical state
of the complexes {precipitated by a second antibody or solubilized by complement). Complexes
in extreme antibody excess, on the contrary, did not yield T cell activation although taken up
by APC efficiently. The effect of antibodies at extreme excess was observed with substimulatory
dose of antigen (loss of potentiation) and with optimal dose of antigen (loss of stimulation).
An excess of specific polyclonal antibodies hampers proteolytic degradation of antigen in vitro,
supporting the view that a similar mechanism may operate within the APC that have internalized
immune complexes in extreme antibody excess. The possibility that immune complex forming
in extreme antibody excess may turn off the T cell response is proposed as a regulatory mechanism.
I
gs, the effector molecules of the immune response produced
by B lymphocytes, have long been known to act also as
positive or negative regulatory elements of the antibody re-
sponse at different levels (1, 2). More recently, it has been
demonstrated that antibodies complexed with soluble antigens
interfere with the T cell response. Inhibitory effect has been
reported in the cytochrome system (3, 4), but enhanced T
cell response has been observed when antibodies bound with
antigen promote Fc receptor-mediated recognition by APC
(5, 6). Complexed antibodies can also influence the fine
specificity of the T cell response (7, 8), possibly by modulating
the processing pattern of antigen internalized by APC in com-
plexed form (9, 10) and the subsequent spectrum ofpeptides
that are made available for MHC binding and presentation
to T cells. These mechanisms affect the selection of the T
repertoire and offera linkage between the previous experience
of the immune system and the current response.
Most of the previous observations were made with mAbs.
Since the in vivo antibody response to protein antigens is
highly polyclonal (11), we tested the regulatory effect of poly-
clonal complexes on the T cell response in a murine and in
a human system. In both cases, antigen/antibody ratio ofthe
complexes proved a critical parameter in dictating either en-
hancement or inhibition of T cell response. Antigen/anti-
body ratio in complexes forming in vivo may vary depending
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on time and on anatomical site, and therefore, it may play
a regulatory on the T cell response.
Materials and Methods
Antigens and Media.
￿
Lyophilized Escherichia coli a-galactosidase
(GZ)' was purchased from Worthington Biochemical Corp., Free-
hold, NJ (sp act, 85,000 EU/mg). 1 enzyme unit (EU) is defined
as the amount of enzyme that liberates 10-9 mol o-nitro-phenyl
(ONP) from ONP-D-galactoside (ONPG) in 1 min in conditions
of substrate excess. Calculations ofEU were made assuming amolar
extinction of ONP corresponding to 4,700 at pH 9 (12) . Purified
protein derivative (PPD; Statens Seruminstitut, Copenhagen, Den-
mark) and tetanus toxoid (TT MassachusettsPublic Health Labora-
tories, Boston, MA) were used to generate humanantigen-specific
T lines. RMPI 1640 (Flow Laboratories, Irvine, Scotland) sup-
plementedwith 100U/ml penicillin, 100 P.g/ml streptomycin, 10
mM glutamine, 5 x 10 -s M 2-ME, and enriched with 10% FCS
(Sterile Systems, Inc., Logan, UT) or with 5% autologous human
plasma was used with murine cells or with human cells.
Murine and Human T Cell Lines and Clones.
￿
GZ-specific mu-
rine T lines were generated according to the protocol originally
described by Kimoto and Fathman (13), with minormodifications
' Abbreviations used in this paper: EU, enzyme units; GZ, 0-galactosidase;
HAGG, heat-aggregatedrabbit gamma globulins; ONPG, o-nitro-phenyl-
n-galactoside; PEC, peritoneal exudatecells;PPD, purified protein derivative;
RAGZ, rabbit anti-GZ; TT, tetanus toxoid.
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the HATsensitiveT lymphoma BW5147 at a 1:1 ratio, as described
by Kappler et al. (15) with minor modifications (16). Hybridoma
clones were obtained by limiting dilution and screened for GZ
specificity by testing antigen-dependent production of IL2, as de-
scribed (16) . Clone 1.7.1 was used in the experiments. PPD- and
TTspecific humanTlineswere generatedfrom PBL obtained from
a normal donor (F.M.) andpurified on a Ficoll gradient. The cells
were resuspended at 2 x 106/ml in complete medium, and 1.5 ml
was dispensed in 24-well plates (Costar, Cambridge, MA). PPD
andTT were addedat 25 and 10 FAg/ml finalconcentration, respec-
tively. After 5 d, the cultures were split at 4 x 10, cells per well,
and humanrIL2 (kindly provided by Hoffman-La Roche, Inc., Basel,
Switzerland) was added at 30 U/ml. 6 d later, 2 x 105 blast cells
were restimulated with antigen plus 5 x 105 autologous 3,000-
rad irradiated PBL. After 2 d, thecells were expanded with rIL2
for 4-7 d. Cycles of antigen and IL-2 stimulation were repeated
forthe maintenance ofthelines. Afterfour cycles of restimulation,
the lines were cloned by limiting dilution at 0.5 cells per well in
round-bottomed microtiter plates containing antigen, rIL2, and
105 irradiated PBL. Positive wells were expanded and restimulated
as thebulk lines. Clone FT1.12 (TT specific)andcloneFP2.6 (PPD
specific) were used in the experiments.
Antisera.
￿
Rabbit anti-GZ serum was raised in NZW rabbits
by using the priming protocol previously described (12). Serum
aliquots were stored at -20°C. Precipitation curves were obtained
by mixing 0.2 ml GZ solution at 10 p,g/ml with 0.2 ml heat-
inactivated rabbit antiserum or affinity-purified antibodies at var-
ious dilutions. After a 4-h incubation at room temperature, the
tubes were spun in a microfuge at 15,000 rpm for 10 min. The
residual enzymaticactivity in the supernatants wasmeasured using
ONPG as thechromogenic substrate (12). Affinity-purified rabbit
anti-GZ antibodies were eluted from a Affi-gel-complexed GZ
column (Bio-Rad Laboratories, Richmond,CA) with glycinebuffer
(pH 2.8) and neutralized with Tris buffer.
Human anti-tetanus toxoid antibodies were obtained as acom-
mercial preparation (Tetuman, Serotherapeutic Institute, Bern, Swit-
zerland). The IgG fraction was dialyzed against PBS, sterile filtered,
and stored at 25 mg/mlat 4°C. Precipitation curves were obtained
by mixing 200 /Al radioiodinated antigen at 10 ng/ml containing
104 cpm with an equal volume of antibodies at different concen-
trations. After a 4-h incubation at room temperature, the tubes
were spun in a microfugeat 15,000 rpm for 10 min. The superna-
tants were removedandtheirradioactivitywas measured in a gamma
counter (LKB Instruments, Inc., Gaithersburg, MD). Rabbit serum
anti-human transferrin andhumantransferrin were purchasedfrom
Behringwerke (Marburg, FDR). A precipitation curve was per-
formed with radioiodinated transferrin at 40 Ag/ml, containing
104 cpm. Residual antigen in the supernatants of the complexes
was determined as described above.
IL2 Production by Murine T Hybridoma Cells and Prolferative Re-
sponse ofHuman T Cells. Peritoneal exudatecells(PEC) were used
as APC for T hybridomas. Peritoneal exudate was induced with
oneintraperitoneal injection of 2 ml Thioglycollate broth (Difco
Laboratories Inc., Detroit, MI). The peritoneal cavity was washed
4d laterwith 8 ml ice-cold complete RPMI 1640 without serum.
The cells were washed twice, resuspended in complete medium,
and counted after staining with crystal violet . Lymphocytes, ac-
counting for 20-30% of the cells, were not considered. Antigen
and antibodies (20,ul each)were dispensedin flat-bottomedmicro-
titer plates andpreincubated for2hat room temperature. Antiserum
was diluted in heat-inactivated normal rabbit serum and affinity-
purified antibodies in normal rabbit gammaglobulins. PEC (5 x
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10') and T hybridoma cells (2 x 104) were added to a final volume
of 200 ul. After 24 h, the supernatants were harvested and tested
for 11,2 production on theIIr2-dependent line CTLL as described
(16),theamount ofsupernatant being 25 ttlat afinaldilution of 1:4.
Inhibition experiments were performedwith mAb 2AG2, kindly
donated by Dr. J. Unkeless, Mount Sinai Medical Center, New
York, specific for mouse FcR. Macrophages were pretreated for
1hat 37°C with theanti-FcR mAb, or with heat-aggregated rabbit
gamma globulins (HAGG; 62°C for 10 min) before addition of
T cells and immune complexes.
Proliferative response by human T clones was measured by cul-
turing 2 x 104 T cells plus 105 autologous irradiated PBL in 200
/Al medium in flat-bottomed microtiter plates. After30 h, the wells
were pulsed with 0.5 p,Ci ['H]TdR (5 Ci/mmol; Amersham In-
ternational, Amersham, UK) and harvested 12 h later. Complexes
were prepared in the culture wells with antigen and antibody at
10-fold dilutions in 20 I1 volume. 2 h later, cells in 200,ul were
added. Final antigen concentrationand antibody concentrationare
shown in Results.
Effect of Complement on Potentiation.
￿
Lyophilized rabbit com-
plement (Behringwerke) andguinea pigcomplement (Sclavo, Siena,
Italy) were reconstituted with distilled water and sterile filtered.
Human complement was freshhuman serum stored in aliquots at
-80°Cfrom donorF.M. tested for lack of toxicity on mousecells.
Complement (20P1)wasaddedto complexed antigen andincubated
at 37°C for an additional hour. PEC and T cells were added and
cultured as described above.
Digestion ofGZ with ProteolyticEnzymes.
￿
GZ waspreincubated
with affinity-purified antibodies overnight at room temperature.
The pH was brought to 5with acetatebuffer (0.1 M, pH 4), and
pepsin (Sigma Chemical Co., St.Louis, MO)wasadded as described
in detail in thefigure legends. Digestionwith cathepsin D (Sigma
Chemical Co.) was performed at pH 6 under similar conditions.
Digestion with V8 protease (Sigma Chemical Co.) was performed
in Tris-HCI buffer (0.5 M, pH 8). After incubation at 37°C for
different time intervals, samples were neutralized with Tris buffer
(1 M pH 8) and tested for residual enzymatic activity or analyzed
for cleavage of the GZ monomer by SDS gel electrophoresis.
SDS GelElectrophoresis.
￿
GZ wasradioiodinated with theBolton-
Hunter reagent (Amersham International) after the instructions
provided by the manufacturer. Specific radioactivity of the sample
was 3.4 x 105/cpm per hg protein. Gel electrophoresis was per-
formed in a mini gel apparatus (Bio-Rad Laboratories), and the
gels were dried and autoradiographed on Hyperfilm (Amersham
International).
Results
Potentiating Activity ofPolyclonal Antibodies.
￿
The effect of
complexing antigen with specific polyclonal antibodies on
presentation by macrophages to a specific T hybridoma clone
is illustrating in Fig. 1. Exposing T cells to antigen alone
results in detectable stimulation only when antigen concen-
tration is >3 Ag/ml (Fig. 1 a). In contrast, in the presence
of rabbit anti-GZ (RaGZ) polyclonal antibodies at 1:250 and
1:50 dilution, antigenconcentration of0.3 htg/ml is stimula-
tory (b andc). Higher antibody concentrationinhibits poten-
tiation (d) and also prevents presentation ofastimulatory dose
of antigen (e). When appropriate complexes are used (1:50
RaGZ, 1 Ftg/ml GZ; (c), the peak production of IL-2 is higher
than in the presence ofoptimal concentration offree antigen0
a
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Figure 1 .
￿
Complexed antibodies allow specific T cell activation by an-
tigen at a substimulatory dose. Antigen was used at various concentra-
tions (abscissa) to induce activation of GZ-specific T hybridoma cells mea-
sured as IL-2 production. The proliferative response of the IL-2-dependent
line CTLL is shown on the ordinate. RaGZ was absent (a) or was added
at 1:250, 1:50, or 1:10 dilutions. The dashed vertical line indicates that
a nonstimulatory dose ofGZ (1 wg/ml) stimulates T cell response in the
presence of antibodies at appropriate concentrations only. The dotted ver-
tical line shows that theoptimal dose ofGZ (10 p.g/ml) isno longer stimula-
tory when complexed with neat immune serum.
at 10 Ag/ml. This suggested that we explore more accurately
the effect of antigen/antibody ratio in the system.
Effect ofAntigen/Antibody Rutia
￿
GZ was mixed with in-
creasing concentrations of RaGZ. The precipitation curve (Fig.
2, solid line) was determined, and the macrophage-mediated
stimulatory effect of the various complexes on T cells was
evaluated as shown in Fig. 2 a. The dashed line indicates IL-2
production by T cells in the presence of immune complexes
at the same ratios as used for the precipitation experiment.
Similar curves were obtained with three additional T hy-
bridoma clones (data not shown). In all cases, optimal stim-
ulation was obtained with complexes in moderate antibody
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Figure 2.
￿
Optimal antigen/antibody ratio is required for potentiation.
GZ was complexed with RaGZ (a) and with affinity-purified antibodies
(b) at various dilutions, as shown on the abscissae. The solid line shows
the precipitation curve ofthe complexes (EU in the supernatants aftercen-
trifugation, on the left ordinates). The same complexes were added to PEC
to induce T cell activation (dashed lines), measured as 11,2 production
(proliferative response of the CTLL line on the right ordinates). Final an-
tigen concentration in cultures was 0.3 Ag/ml. Background proliferation
without antigen was 2,100 cpm.
excess. Extreme antibody excess (right end of the curve) or
extreme antibody defect (left end of the curve) decrease the
efficiency of presentation to the level of antigen alone.
To eliminate any potential interference of serum proteins
other than antibodies, the experiment was repeated with
affinity-purified antibodies. Fig. 2 b confirms that in this case
also, complexes with extreme antibody excess are no longer
effective for potentiation, and that potentiation occurs with
complexes at optimal ratio (equivalence or moderate excess).
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Figure 3.
￿
T cells respond to antigen complexed at optimal ratio at a
2-log lower dose than antigen alone. Complexes corresponding to optimal
ratio (solid circles) and to extreme antibody excess (open circles) in Fig. 2
were prepared with GZ and with RaGZ. After incubation for 1 h, the
complexes were serially diluted and tested for capacity to induce T cell
activation. Final concentration of complexed or free antigen (squares) is
on the abscissa. As little as 0.015 t~g/ml GZ induces a detectable stimula-
tion of T cells. GZ at stimulatory concentration when in free form (8
tug/ml) no longer stimulates when complexed in extreme antibody excess.
Fig. 3 shows a titration curve ofcomplexes at different ratios.
Complexes were prepared by mixing the reactants and were
diluted after incubation. As little as 15 ng/ml antigen can
be detected in complexes with optimal ratio. In contrast, com-
plexes with excess antibodies were nonstimulatory even when
final antigen concentration was stimulatory by itself. This
indicates that antibody excess blocks potentiation in the first
case and inhibits presentation in the second case.
Antibody Excess Does Not Interfere with Presentation ofProcessed
Antigen.
￿
We tested whether the lack of T cell stimulation
Table 1 .
￿
Antibody Excess Does Not Affect Presentation
RaGZ at various dilutions and GZ (1 tug/ml) were preincubated with
APC for 4 h at 37°C . Normal rabbit serum (NRS) or RaGZ (20 tul)
were added, and 4 h later, T cells were dispensed in the wells. IL-2 produc-
tion in the supernatants was measured on CTLL cells, and results are
given as thymidine incorporation by the indicator line (±
￿
SD).
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￿
Potentiation of T cell activation depends on Fc receptors on
APC. (a and b) PEC were preincubated with HAGG (a) and with anti-
FcR mAbs (b) at various concentrations (abscissa) for 1 h. Free antigen
at 10tug/ml final concentration (squares) or optimal complexes corresponding
to 03 tug/ml GZ final concentration (circles) was added to APC along with
T cells. IIT2 production is shown on the ordinate, as thymidine incorpora-
tion by the Ilr2-dependent line CTLL. (c) PEC were preincubated with
transferrin-antitransferrin complexes at various ratios, the final concentra-
tion of transferrin being 10 tug/ml. Precipitation curve of the irrelevant
transferrin-antitransferrin complexes isrepresentedby the dashed line, with
residual radioactive antigen in the supernatants shown on the left ordinate.
Free antigen at 10 tug/ml final concentration (squares) or optimal com-
plexes (circles) containing RaGZ and antigen to give a0.3 tug/ml final con-
centration were added to APC along with responding T cells. IIT2 produc-
tion, measured as the proliferative response ofthe CTLL cells on the right
ordinate, indicates T cell activation.
in the presence of extreme antibody excess was due to a di-
rect inhibitory effect of free antibody on antigen presenta-
tion. For this purpose, APC were pulsed with GZ complexes
at optimal ratio. After washing, immune rabbit serum was
added to the pulsed APC at the concentration corresponding
to antibody excess, alongwith respondingT cells. As shown
in Table 1, large antibody excess has no effect on T cell acti-
vation when APC had been pulsed with complexes at op-
timal antigen/antibody ratio. Therefore, the effect is due nei-
ofProcessed Antigen
Exp. IL-2 production
cpm x 10'
1 (RaGZ [1:50] + GZ) + APC + NRS
[1:10] + T cells 36 ± 4.2
2 (RaGZ [1:10] + GE) + APC + NRS
[1:501 + T cells 4 ± 1 .6
3 (RaGZ [1:50] + GZ) + APC + RaGZ
[1:101 + T cells 42 ± 2.8cpm x 10r-3
20-a
0
.01
￿
.1
￿
1 ,Jg/ml
GZ
Figure 5.
￿
Complement activation by immune complexes further en-
hances potentiation. Complexes were prepared at optimal ratio (100 Al
GZ [10 t~g/ml] plus 100 it] RaGZ [1:64]) with the addition of 100 Al in
diluted complement. After incubation for 2 h at 37°C, complexes were
serially diluted, and 30 Al was added to the culture mixture containing
PEC and T cells. On the (Abscissa)/Final concentration ofGZ in culture.
Free GZ (dashed line), complexed GZ without complement (open circles)
and complexed GZ plus rabbit (squares); guinea pig (solidcircles) and human
(triangles) complement. (Ordinate) IL2 production by activated T cells,
measured as proliferative response of CTLL cells.
ther to toxicity for APC nor to masking of processed antigen
by free antibody in excess.
Role ofFc Receptors in the Mechanisms of Potentiation.
￿
To
confirm that potentiation is due to uptake of complexed an-
tigen by APC via FcR in the case of polyclonal antibodies,
as previously demonstrated with mAbs (8), we used anti-
FcR mAbs or HAGG to functionally block FcR on APC.
Fig. 4 shows that T cell stimulation by complexed antigen
is inhibited when APC had been pretreated with either re-
agent. T cell activation by APC in the presence of optimal
cpm x 10-3
20-1
0 -~ ~-
￿
O
0
￿
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￿
1
￿
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concentration of free antigen (10 NAg/ml; Fig. 4 a and b) is
not affected by either reagent, indicating that only uptake
of complexed antigen is FcR dependent. Furthermore, im-
mune complexes of transferrin and antitransferrin at different
ratios were also tested. Fig. 4 c shows that complexes in anti-
body excess inhibit T cell activation induced by a suboptimal
dose of antigen complexed with specific antibodies at optimal
ratio for potentiation, but T cell activation induced by an
optimal dose of free GZ is not affected. This is consistent
with the concept that potentiation depends on availability
of FcR and that complexes in large antibody excess do not
"engulf" the APC.
Role ofComplement Receptors in the Mechanism ofPotentia-
tion. Since FcRpositive APC also bear complement receptors,
we tested whether complement activation by immune com-
plexes couldfurther facilitate uptake and presentation. Addi-
tion of rabbit, guinea pig, or human complement to immune
complexes provides additional potentiation at low doses of
antigen (Fig. 5) .
Macrophages Are `Armed" Neither by Polyclonal nor by Mono-
clonal Free Antibodies, but Retain Aggregated Antibodies on the
Surface for a Short Period. We tested whether APC can be
armed by polyclonal antibodies thanks to binding of free an-
tibodies to FcR. Fig. 6 a shows that preincubation of APC
with uncomplexed specific antibodies does not facilitate an-
tigen presentation to T cells. This is somehow expected with
polyclonals, since in addition to low affinity of FcR for free
antibody, competition for receptor binding may occur be-
tween the large fraction of nonspecific Igs and the small frac-
tion of specific antibodies. When the experiment was per-
formed with mAb D6C9 in ascitic form (17), in which most
of the antibody molecules are GZ specific, no functional arming
of APC was detectable (Fig. 6 a). mAb D6C9 was selected
from a panel of available monoclonals because, in combina-
tion with T hybridoma clone 1.7.1, it behaves as polyclonal
b
"~
￿
Figure 6.
￿
Aggregated specific antibodies bind and
"
￿
are briefly retained on the surface of APC. (a) DUO
(106 in 1 ml of medium) were pulsed at 37°C for 2 h
with 100 Eel normal rabbit serum (squares), with 100
Eel RaGZ serum (circles), or with 100 AI mAb D6C9
(described in reference 17) at 1 mg/ml prepared from
an ascitic fluid precipitated with ammonium sulfate
(triangles) . PEC were washed twice after incubation
and plated for the assay under normal conditions. GZ
was added in 20 Eel volume as free antigen (final con-
centration on the abscissa). T cell activation, measured
as IIL2-induced proliferative response of CTLL cells,
is on the ordinate. (b) Heat-aggregated (62°C, 10 min)
DEAF-purified IgG fraction from RaGZ at 1 mg/ml
final concentration was preincubated with PEC as
above. After washing, PEC were cultured with T cells.
Antigen at a substimulatory dose (0.3 Erg/ml) or at
an optimal dose (10 Erg/ml) was added at the different
times shown on the abscissa. T cell activation as 11,2
production measured on CTLL cells is shown on the
min
￿
ordinate.
30 90rabbit antibodies, in that potentiation is lost when used in
extreme excess (40:1 nominal ratio), as described previously (8).
Fig. 6 b shows that APC preincubated with polyclonal an-
tibodies in aggregated form can present a substimulatory dose
of antigen to T cells, provided antigen is given within 10
min after pulsing. On the other hand, APC can present a
stimulatory dose of antigen at any time after pulsing with
aggregated antibodies. This suggests that aggregated anti-
bodies bound to the cell surface are retained for a short period
and are likely internalized afterwards.
Adherent PeritonealMacrophages Are ResponsibleforPotentia-
tion. Peritoneal exudates contain several cell types capable
of antigen presentation, namely, macrophages, dendritic cells,
and B lymphocytes. Antibody-potentiatedpresentation is FcR
dependent, therefore, dendritic cells that are FcR negative
cannot be involved in this phenomenon. To discriminate be-
tween macrophages and B cells, peritoneal exudate cells were
separated between adherent and nonadherent populations.
Potentiating capacity was retained intact by adherent macro-
phages, whereas the nonadherent fraction containing the B
cells had negligible capacity to present complexed antigen
(Table 2). This was confirmed by using spleen cells that con-
tain a large fraction of B lymphocytes, depleted of adherent
macrophages (Table 2). It should be noted that presenting
function of optimal concentration of antigen was exerted also
by the nonadherent fraction.
Clearance ofComplexed Antigen by APC as a Measure ofAn-
tigen Uptake. Since antigen uptake is a dynamic process as-
sociated with release of degraded antigen fragments (18), ac-
tual accumulation of antigen in APC is difficult to evaluate.
Therefore, we assumed that removal of intact antigen from
culture supernatants, depending on the presence ofAPC and
Table 2.
￿
Adherent Peritoneal Macrophages Are Responsible for
Potentiated Presentation of Complexed Antigen
PEC and spleen cells were plated at 5 x 103 and 50 x 104/well, respec-
tively. After a 6-h incubation at 37°C, nonadherent cells were gently
resuspended and transferred to new wells. Medium was addedto the wells
containing the adherent cells. T cells and antigen (10 Pg/ml free GZ or
0.3 ttg/ml GZ complexed with affinity-purified antibodies at optimal ra-
tio) were added to the presentingcells, and the assay for IL-2 production
was performed as described. Results are shown as cpm x 10-3 thymi-
dine incorporation by the IL-2-dependent line CTLL.
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of specific antibodies, is a measure of uptake of complexed
antigen.
Complexes were prepared by mixing 1 jig/ml GZ with
an equal volume of RaGZ at various dilutions, as indicated
in Fig. 7. After incubation, the complexes were added to 106
PEC in 24-well plates (Costar) in 1 ml medium to a final
concentration of 0.1 p,g/ml GZ. After 5 h, the supernatants
were harvested and residual intact antigen was measured as
enzyme activity. No loss in enzymatic activity was seen upon
incubation of free antigen in wells with or without PEC.
No loss in enzymatic activity was seen in wells containing
complexed antigen without APC. Fig. 7 shows the results
expressed as percent difference of enzyme activity between
input antigen and residual antigen after incubation, defined
as antigen uptake. Uptake was evident when complexes had
been prepared with RaGZ at a 1:40 or higher concentration.
Therefore, complexes at extreme antibody excess (right end
of the curve) are cleared from the culture supernatant, sug-
gesting that extreme antibody excess does not prevent effec-
tive uptake, in contrast with reduced effectiveness when the
same complexes are used to stimulate antigen-specific T cells,
as shown in Fig. 2 .
% uptake
t00--%
so
RaGZ
t :10
Figure 7.
￿
Clearance ofcomplexed antigen by APC as a measure ofup-
take depends on antibody/antigen ratio. Complexes were made with GZ
(1 jug/ml) and RaGZ at various dilutions as shown on the abscissa, and
incubated 2 h at room temperature. Complexes were added to 106PEC
in 1 ml of medium in 24-well plates (Costar) to a final concentration of
0.1 p,g/ml GZ. After 5 h at 37°C, residual enzymatic activity was mea-
suredin the supernatants by harvesting 100,ul medium. No spontaneous
sedimentation at 1gwas detectable with complexes that precipitate when
submitted to centrifugation, as observed with supernatants from control
wells without PEC. Decreased enzymatic activity is seen in supernatants
ofwellscontaining PECand complexed antigen with RaGZ at 1:40, 1:20,
and 1:10 dilution. No detectable decrease of enzymatic activity occurs in
the absence of antibodies. The ordinate shows the percent difference be-
tween input EU and recoveredEU,defined as APC-dependent and antibody-
dependent uptake.
APC
Antigen
Free GZ
in culture
GZ complexed
with antibodies
PEC 18 20
Adherent PEC 21 17
Nonadherent PEC 16 3
Spleen cells 26 21
Adherent spleen cells 20 25
Nonadherent spleen cells 20 2Table 3 .
￿
Complexed Antibodies Protect GZ from
Proteolytic Degradation
Affinity-purified antibodies
Proteolytic enzyme
￿
500 pg/ml
￿
100 hg/ml
￿
20 hg/ml
Pepsin
￿
75 (4)
￿
20 (1)
￿
5 (0)
Cathepsin D
￿
100 (40)
￿
50 (14)
￿
35 (5)
V8 protease
￿
100 (30)
￿
100(1)
￿
55 (0)
GZ was complexed with affinity-purified antibodies at different concen-
trations, corresponding to complexes in extreme antibody excess, equiva-
lence, and antibody defect (see precipitation curve shown in Fig . 2 b) .
Digestion with proteolytic enzymes was carried out for 30 min . Results
are shown as percent residual enzymatic activity, assuming 100% as the
input activity. Residual enzymatic activity of samples containing GZ and
nonspecific rabbit gamma globulins at the same concentrations (nonpro-
tected controls) is shown in parentheses .
Proteolytic Degradation ofComplexed Antigen .
￿
Extreme an-
tibody excess neither inhibits antigen presentation (Table 1)
nor blocks removal of complexed antigen by APC taken as
a measure of antigen uptake (Fig. 7) . Therefore, we tested
whether extreme antibody excess hampers proteolysis of an-
tigen. Complexes were constructed with affinity-purified an-
tibody excess at neutral pH and digested with pepsin at pH
5, with cathepsin D at pH 6, and with V8 protease at pH
8 . AcidicpH allows proteolytic activity of pepsin and cathepsin
D, but does not interfere with antigen-antibody interactions,
as tested with an ELISA (data not shown) . At various time
intervals, samples from the reaction mixtures were collected
and neutralized to block proteolytic activity of pepsin and
Figure 8 .
￿
Specific antibodies protect complexedGZ from enzymatic pro-
teolysis. Radioiodinated GZ was digested with pepsin, cathepsin D, and
V8 protease for 30 min . Digestion was stopped by adding SDS-2ME and
heating at 100°C . (Lanes 1, 4, and 7) . Undigested GZ ; (lanes 2, S,
and 8) GZ complexed with affinity-purified antibodies in large excess and
digested with enzymes ; (lanes 3, 6, and 9) GZ plus an equal amount of
normal rabbit gamma globulins digested with enzymes . Samples were run
on a 7.5% SDS gel and autoradiographed afterfixation with TCA-methanol .
Molecular mass markers correspond to: GZ, 116 ; phosphorylase, 97; BSA,
66; OVA, 42; carbonic anhydrase, 31; soybean trypsin inhibitor, 21 ; and
lysozyme, 14.
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￿
Precipitation ofcomplexes does not account for potentiation .
(Leftpanels) Complexes were prepared by using equal volumes ofantigen
at 1 tog/ml and RaGZ at various dilutions as indicated on the abscissa .
One volume heat-inactivated normal rabbit serum (1:100) was added to
the complexes . Precipitation in c was obtained by adding one volume goat
anti-rabbit gamma globulin serum 1:4 for an additional 2 h . Precipitation
of the the complexes was evaluated as residual antigen in the supernatants
(EU on the left ordinate) after centrifugation. In the presence of goat
anti-rabbit gamma globulin, serum also soluble complexes in extreme an-
tibody excess precipitate . (Right panels) Complexes containing the second
antibody were also tested for T cell activation by adding 40 Ftl of the mix-
ture to cultures . Final GZ concentration was 0 .1 Rg/ml . The T cell
stimulating capacity of the complexes (b) and of the complexes precipi-
tated by the second antibody (d) is shown . IIT2-induced proliferative re-
sponse ofCTLL cells as a measureofT cell activation is on theright ordinate.
cathepsin D, or mixed with an equal volume of normal rabbit
serum to block V8 protease activity. Neutralization also re-
stores enzymatic capacity ofGZ. Table 3 demonstrates that
proteolytic activity ofpepsin, cathepsin, andV8 protease mea-
sured as loss of catalytic activity of GZ is greatly inhibited
when antigen is complexed with specific antibodies in large
excess, as compared with control samples containing normal
rabbit gamma globulins.
Radioiodinated GZ was complexed with antibodies in excess
or mixed with normalgamma globulins. Digestion with pro-
teolytic enzymes was performed as described. Complexing
with affinity-purified antibodies protects GZ from degrada-
tion by proteolytic enzymes effective at different pH (Fig.
8) . In particular, digestion by cathepsin D, one of the en-
dosomal enzymes involved in antigen processing, is completely
prevented by antibodies . It should also be noted that diges-
tion withV8 protease yields low molecular mass fragments
(<14 kD) that are retained in the gel. In contrast, when pro-
teolysis is performed with pepsin or cathepsin, no low mo-Figure 10.
￿
Complement-dependent solubilization does not prevent ac-
tivity ofpotentiating complexes. (Left panels) Precipitation of complexes
tested as residual enzymatic activity of supernatants after centrifugation
on the left ordinate was inhibited by adding fresh rabbit serum as a source
of complement (a vs. c). (Rightpanels) Tcells stimulation (IL2-dependent
proliferation ofCTLL cells on the right ordinate) by complexes or bycom-
plement solubilized complexes (b and d) is optimal with complexes in
moderate antibody excess, even in the absence of precipitation. Final an-
tigen concentration was 0.1 gg/ml.
lecular weight fragments are retained in the gel matrix after
TCA fixation.
Precipitation ofComplexedAntigen Does Not Accountfor Poten-
tiation. To test whether potentiation is due to antibody-
induced antigen precipitation and consequent concentration
of antigen in proximity of APC, we set up two different ex-
periments. In the first one, all complexes were precipitated
with goat anti-rabbit gamma globulin, irrespective of their
ratios. Fig. 9 shows that soluble complexes in antibody excess
are precipitated, as well as complexes at equivalence (a vs.
c). Nevertheless, complexes in extreme antibody excess are
ineffective for T cell stimulation, even though precipitated
by the second antibody (b vs. ti). Furthermore, only com-
plexes prepared with moderate antibody excess are stimula-
tory. In the second experiment, precipitation of complexes
was prevented by using complement to solubilize immune
complexes (19). Fig. 10 shows that in the presence of fresh
rabbit serum as a source of complement, precipitable com-
plexes do not form at any antibody-antigen ratio (a vs. c).
Complexes are effective for T cell activation when antibody
is at optimal ratio even in the absence of precipitation, and
extreme antibody excess yields ineffective complexes even in
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￿
Activation of TTspecific human T cells is potentiated by
complexes at optimal ratio. (a) Titration ofTT on FT1.12 clone. The dose
of0.01 itg/ml waschosen as nonstimulatoryand was used for the potenti-
ation experiment. (b) Precipitation curve of radiolabeled TT (104 cpm,
0.1 Ftg/ml) incubated with an equal volume of antiTT antibodies at var-
ious concentrations. Radioactivity was measured in the supernatants after
incubation for 4 h at room temperature and centrifugation. No sponta-
neous sedimentation of radioactive antigen occurred at 1 g after 48 h. (c)
TTspecific cells are activated by 0.01 Irg/ml TT complexed with anti-
bodies at optimal concentration (25 Fcg/ml). No potentiation was seen
with complexes at extreme antibody excess (right end of the curve). The
same complexes (open circles), even at nonstimulatory ratios, or the same
doses of noncomplexed antibodies (solid circles), did not interfere with
proliferative response of the PPD-specific clone FP2.6 to PPD.
the presence of complement (b vs. d) . Complement added
to complexes at optimal ratio further enhances potentiation,
as shown also in Fig. 5.
Effect ofAntigen/Antibody Ratio on Activation ofAntigen-speck
Human T Cells.
￿
To test the effect of antigen/antibody ratio
.025 25 25 25 250
20 a
of
025 25 2 .5 25 250on T cell activation in a different system, we used TT and
a TTspecific human T clone. Antigen was given to T cells
at a substimulatory dose (0.01 jig/ml, as defined by titration
curve in Fig. 11 a) complexed with antibodies. Complexes
were prepared at various ratios as shown in the precipitation
curve (Fig. 11 b).
Fig. 11 c shows that optimal T cell stimulation occurs with
complexes at optimal ratio, corresponding to moderate anti-
body excess. Complexes at equivalence are not as effective,
and complexes at extreme antibody excess do not yield T cells
stimulation. Fig. 11 c also shows that nonstimulatory com-
plexes, or antiTT antibodies alone, have no inhibitory effect
on a PPD-specific clone stimulated with the relevant antigen.
Discussion
The capacity of bound Igs to facilitate uptake of corpus-
cular antigens by phagocytic cells has long been known as
opsonization (20). More recently, the capacity of Igs to en-
hanceuptake of soluble antigens by macrophages, that in turn
present processed antigen to specific T cells, has been described
as enhancement or potentiation (5). Therefore, antibodies facili-
tate recognition of minute amounts of antigen that cannot
be taken up effectively by accessory cells. In this regard, mac-
rophages as accessory cells strikingly differ from antigen-
specific B cells that make use of surface Igs to focus on an-
tigen while exerting their accessory function (21, 22).
The potentiating activity has been described with poly-
clonal antibodies (5), and subsequently with mAbs (6-8).
The mechanisms and the implications of receptor-mediated
antigen uptake on presentation to T cells has been recently
reviewed (23).
We explored the effect of antigen/antibody ratio in com-
plexes as a variable that possibly influences uptake, processing,
and presentation of antigen. When complexes constructed
at different ratios were given to macrophages, T cell activa-
tion only occurred with complexes in a limited range of an-
tigen/antibody ratios. In particular, complexes in extreme an-
tibody excess were poor stimulators for T cells, whereas
complexes close to equivalence, as defined by precipitation
curves, provided optimal potentiation. Extreme antibody excess
does not only abrogate the potentiating effect of complexed
antibodies for subliminal dose of antigen, but it also prevents
effective presentation ofantigen at optimal stimulatory dose.
A possible influence of antigen/antibody ratio on complex
uptake was tested. By measuring the clearance ofcomplexed
antigen in the presence of APC, evidence was obtained that
extreme antibody excess does not inhibit uptake.
Complexes endowed with optimal potentiating capacity
are close to equivalence and are precipitable only in part by
centrifugation. Therefore, antigen focusing in proximity of
APC may account for potentiation. Nevertheless, the following
arguments stand against such a possibility: (a) complexes at
equivalence are not the most effective complexes for potenti-
ation; (b) potentiation is mediated by FcR (Fig. 4) and not
by simple antigen uptake by APC, as shown in the inhibi-
tion experiments with anti-FcR mAbs, with HAGG, and
with unrelated immune complexes; (c) precipitation ofcom-
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plexes used for experiments is detected only after centrifuga-
tion, and at 1 g, as in the culture wells, sedimentation of
complexes is negligible during incubation with cells (data
not shown); (d) antibody excess complexes that precipitate
in part and do not potentiate acquire no stimulatory capacity
upon precipitation with a second antibody (Fig. 10 d); (e)
optimal complexes at moderate antibody excess retain poten-
tiating capacity when solubilized with complement (Figs.
5 and 11). Similar results were obtained when affinity-purified
antibodies were used for the preparation of the complexes,
indicating that serum proteins other than antibodies are not
responsible for the effects described. The complexes used in
the experiments at different ratios were defined according to
precipitation curves (equivalence, moderate, and extreme an-
tibody excess) . Complexes at equivalence can be character-
ized for actual antibody/antigen ratio since all available an-
tigen and antibody molecules are present in the precipitate.
Such a molar ratio was close to 10 in GZ-containing com-
plexes (data not shown). In contrast, complexes that partially
precipitate (moderate antibody excess) or do not precipitate
(extreme antibody excess) cannot be accurately defined for
actual molar ratio, but only for nominal ratio of the reac-
tants in the mixture.
The diversity of Fc receptors on APC (reviewed in refer-
ences 24 and 25) should be considered in this discussion. FcRI
is a 70-kD glycoprotein with high affinity for monomeric
IgG (26). Nevertheless, binding ofmonomeric polyclonal or
monoclonal antibodies by APC was not evident when tested
in a functional assay in which antigen was given immedi-
ately afterpulsing with monomeric antibodies and T cell ac-
tivation was used to measure antigen presentation (Fig. 6).
In particular, mAb D6C9, used for this experiment was pre-
viously reported to behave similarly to polyclonal antibodies,
in that large excess in the complexes prevents activation of
T clone 1.7.1 (8). This effect of mAb D6C9 was not evident
with other T clones, suggesting that in the presence of this
mAb processing of antigen is influenced in such a way that
only the epitope recognized by clone 1.7.1 was not effectively
presented. In this respect, interference by an excess ofmono-
clonal and polyclonal antibodies may differ. mAbs may affect
appropriate processing of one limited region of the antigen,
as described in the myoglobin system (7), whereas polyclonal
antibodies may interfere with the overall degradation of the
antigen molecule. FcRII, a 40-kB glycoprotein, has low affinity
for monomeric IgG, and is more specific for complexed Igs.
FcRII is recognized by mAb 2AG2 (27), which inhibits poten-
tiation almost completely. Therefore, FcRII is a candidate
to be the most relevant receptor for potentiation. Murine
FcRIII is poorly characterized and does not seem to partici-
pate effectively in potentiation when FcRII is blocked by
monoclonal 2AG2.
Antibody excess is not detrimental during the step of an-
tigen presentation (Table 1). This suggests that free antibody
does not interfere with surface expression of processed an-
tigen by APC preventing its interaction with the specific T cell.
The experiments show that extreme antibody excess pre-
vents enzymatic degradation of antigen hidden in the core
of the complex (Fig. 8), possibly by sterically hindering thecontact between antigen and proteolytic enzyme(s). The ex-
periment was carried out with pepsin at pH 5, which is similar
to or lower than the pH in the acidic compartments where
processing is likely to occur (28); with cathepsin D, a repre-
sentative endosomal enzyme (29) at pH 6; and with V8 pro-
tease, a proteolytic enzyme commonly used for protein finger-
printing, at pH 8.
mAbs protect antigens from proteolysis (30), and in par-
ticular, some well-defined regions in spacial proximity to the
relevant epitope (31-33) . Interferences of antibodies with in-
tracellular degradation of TT taken up by monoclonal an-
tigen-specific lymphoblastoid lines confirms that mAbs can
modulate antigen processing (9), as we previously proposed
(8). In particular, monoclonal B lymphoblastoid cells with
different fine specificities for TT generate different degrada-
tion products upon uptake and internalization ofantigen medi-
ated by the surface Ig receptor (10) . It is likely that in the
case of polyclonal antibodies, which bind to different epi-
topes on the antigen molecule, this protective mechanism is
even more efficient.
Therefore, potentiation of antigen presentation may result
from a balance between moderate antibody excess, which facili-
tates uptake of complexed antigen without blocking degra-
dation, and extreme antibody excess, which shields the an-
tigen molecule from processing by the APC. Furthermore,
when complexes in large antibody excess are presented to APC,
many FcR are engaged to internalize immune complexes that
contain a low amount of antigen relative to the number of
Ig molecules, suggesting the functional concept of much work
for a poor catch. The interference of unrelated immune com-
plexes (transferrin-antitransferrin) in large antibody excess with
FcR-mediated potentiation, but not with presentation of an
optimal dose of free antigen, indicates that lack of stimula-
tion by antibody excess complexes is not due to nonspecific
functional engulfment of APC.
Potentiation in the system we describe is chiefly mediated
by adherent macrophages, the major cellular component of
peritoneal exudate. Nonadherent cells in the exudate capable
of antigen presentation, i.e., B cells and dendritic cells, were
unable to present low doses of complexed antigen. This is
expected with FcR-negative dendritic cells, and the failure
of FcRpositive B cells to bring aboutpotentiation is in agree-
ment with the observation that human B cells cannot present
TT in complexed form to specific T cells (34).
Since complexes also form in vivo, activated and bound
complement factors may further enhance uptake by APC by
binding to complement receptors. An enhancing effect was
seen in vitro, suggesting that complement receptors also par-
ticipate in potentiation of antigen uptake. Enhanced phago-
cytosis mediated by receptors for complement (35) and en-
hanced degradation of Ig aggregates by macrophages in the
presence of complement (36, 37) have been described, but
a role for complement receptors on APC has not been related
so far to potentiation of antigen presentation to T cells.
The effect of antigen/antibody ratio on potentiation was
also examined with human T cells and human polyclonal an-
tibodies. When complexes are constructed at extreme anti-
body excess, potentiating capacity is lost. Also, in this case,
the effect cannot be attributed to engulfment of APC by an-
tibody excess complexes, since presentation of an unrelated
antigen such as PPD to PPD-specific T cells was not impaired.
Therefore, potentiation by complexes at the appropriate ratio
appears to be a more general phenomenon in different spe-
cies and in different antigenic systems.
Potentiation may also be a relevant in vivo event with dis-
tinctfunctions. Complement is available in vivo and its acti-
vation by complexes may further facilitate uptake by acces-
sory cells. Precipitation ofcomplexes is less likely to take place
in vivo where complement exerts its solubilizing activity (19).
Antigen/antibody ratio may change at different times and
in different compartments. Therefore, complexed antigen may
appear in a stimulatory or a nonstimulatory form. Theseevents
may participate in the regulation of the T cell response. In
particular, when boosting antigen meets with residual anti-
bodies during a secondary response, complexes that form facili-
tate uptake of nonstimulatory doses of antigen by APC
resulting in T cell activation. T cell clonal expansion ensues
and further increases the chances for a specific T cell to en-
counter a specific B cell (38).
When secreted antibodies reach a concentration that largely
overcomes antigen concentration, complexes in antibody excess
form. One can speculate that this leads to withering of T
and B responses. In fact, if antigen is complexed with excess
antibodies, there are no epitopes available for binding to sur-
face Igs on specific B cells. Specific B cells cannot take up,
process, and present the antigen to specific T cells and gain
help in turn for antibody production. In addition, even though
antigen is taken up as a complex by APC, antibody excess
hinders its appropriate degradation and processed antigen is
no longer available, with a consequent fading of the T cell
response as well.
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